1,889 results on '"Wilcox, Mark"'
Search Results
2. Impact of interventions to reduce nosocomial transmission of SARS-CoV-2 in English NHS Trusts: a computational modelling study
3. High-resolution freshwater dissolved calcium and pH data layers for Canada and the United States
4. European Practice for CDI Treatment
5. Russia and the treaty on Conventional Armed Forces in Europe (CFE Treaty)--a paradigm change?
6. Unintended strategic consequences of security assistance in the South Caucasus
7. Colonel General Boris Vsevolodovich Gromov, Deputy Minister of Defense of the Russian Federation: A biographical study
8. Integrating seascape resistances and gene flow to produce area-based metrics of functional connectivity for marine conservation planning
9. Clostridioides difficile canonical L,D-transpeptidases catalyze a novel type of peptidoglycan cross-links and are not required for beta-lactam resistance
10. Decoding a cryptic mechanism of metronidazole resistance among globally disseminated fluoroquinolone-resistant Clostridioides difficile
11. A cost-utility analysis of two Clostridioides difficile infection guideline treatment pathways
12. Redefining Clostridioides difficile infection antibiotic response and clinical outcomes
13. Clostridioides difficile infection: are the three currently used antibiotic treatment options equal from pharmacological and microbiological points of view?
14. How to: Clostridioides difficile infection in children
15. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial
16. The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis
17. Treatment outcomes of secondary bacteraemia in patients treated with ceftaroline fosamil: pooled results from six phase III clinical trials
18. A global perspective on improving patient care in uncomplicated urinary tract infection: expert consensus and practical guidance
19. Impact of Underlying Comorbidities on Outcomes of Patients Treated with Ceftaroline Fosamil for Complicated Skin and Soft Tissue Infections: Pooled Results from Three Phase III Randomized Clinical Trials
20. Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing
21. Case Series: Efficacy of Polyclonal Intravenous Immunoglobulin for Refractory Clostridioides difficile Infection
22. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults
23. Serum luteal phase progesterone in women undergoing frozen embryo transfer in assisted conception: a systematic review and meta-analysis
24. Healthcare-associated COVID-19 in England: A national data linkage study
25. Development and clinical validation of an automated cell cytotoxicity neutralization assay for detecting Clostridioides difficile toxins in clinically relevant stools samples
26. Safety and efficacy of omadacycline by body mass index in patients with community-acquired bacterial pneumonia: Subanalysis from a randomized controlled trial
27. Global Landscape of Clostridioides Difficile Phylogeography, Antibiotic Susceptibility, and Toxin Polymorphisms by Post-Hoc Whole-Genome Sequencing from the MODIFY I/II Studies
28. Antimicrobial susceptibility in Clostridioides difficile varies according to European region and isolate source.
29. Public health case for microbiome-sparing antibiotics and new opportunities for drug development.
30. Shedding of SARS-CoV-2 in feces and urine and its potential role in person-to-person transmission and the environment-based spread of COVID-19
31. Snapshot PCR surveillance for SARS-CoV-2 in hospital staff in England
32. Factors affecting reported Clostridioides difficile infection rates; the more you look the more you find, but should you believe what you see?
33. Bezlotoxumab for prevention of Clostridium difficile infection recurrence: Distinguishing relapse from reinfection with whole genome sequencing
34. A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbiome and Metabolome Correlates of Response
35. Impact of testing on Clostridioides difficile infection in hospitals across Europe: a mathematical model
36. Clostridioides difficile infection (CDI): A pan-European multi-center cost and resource utilization study, results from the Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI)
37. Multicenter Prevalence Study Comparing Molecular and Toxin Assays for Clostridioides difficile Surveillance, Switzerland
38. Estimating the Value of New Antimicrobials in the Context of Antimicrobial Resistance: Development and Application of a Dynamic Disease Transmission Model
39. European Practice for CDI Treatment
40. Biofilms harbour Clostridioides difficile, serving as a reservoir for recurrent infection
41. The perils of PCR-based diagnosis of Clostridioides difficile infections: Painful lessons from clinical trials
42. The potential of microbiome replacement therapies for Clostridium difficile infection
43. Can SARS-CoV-2 be transmitted via faeces?
44. Ceftaroline fosamil therapy in patients with acute bacterial skin and skin-structure infections with systemic inflammatory signs: A retrospective dose comparison across three pivotal trials
45. Clostridium difficile trehalose metabolism variants are common and not associated with adverse patient outcomes when variably present in the same lineage
46. Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials
47. Evaluating the impact of testing strategies for the detection of nosocomial COVID-19 in English hospitals through data-driven modeling
48. Patient and Strain Characteristics Associated With Clostridium difficile Transmission and Adverse Outcomes
49. Two Distinct Patterns of Clostridium difficile Diversity Across Europe Indicating Contrasting Routes of Spread
50. A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Pathogens : REVIVE-1
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.